Series B · Biotech
ONCOMATRYX: Series B
Develops Quantum ADCs against the tumor microenvironment for metastatic solid tumors
Funding history
Series B · This round$67M
Loading rounds…
Develops Quantum ADCs against the tumor microenvironment for metastatic solid tumors